Protagonist Therapeutics Statistics
Total Valuation
PTGX has a market cap or net worth of $6.49 billion. The enterprise value is $5.85 billion.
Important Dates
The next estimated earnings date is Tuesday, May 5, 2026, after market close.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PTGX has 63.81 million shares outstanding. The number of shares has decreased by -2.31% in one year.
| Current Share Class | 63.81M |
| Shares Outstanding | 63.81M |
| Shares Change (YoY) | -2.31% |
| Shares Change (QoQ) | +0.41% |
| Owned by Insiders (%) | 1.07% |
| Owned by Institutions (%) | 95.80% |
| Float | 51.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 33.93 |
| PS Ratio | 141.00 |
| Forward PS | 18.54 |
| PB Ratio | 10.35 |
| P/TBV Ratio | 10.55 |
| P/FCF Ratio | 115.69 |
| P/OCF Ratio | 112.50 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 127.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 104.36 |
Financial Position
The company has a current ratio of 12.71, with a Debt / Equity ratio of 0.02.
| Current Ratio | 12.71 |
| Quick Ratio | 12.58 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.18 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -20.18% and return on invested capital (ROIC) is -229.61%.
| Return on Equity (ROE) | -20.18% |
| Return on Assets (ROA) | -13.99% |
| Return on Invested Capital (ROIC) | -229.61% |
| Return on Capital Employed (ROCE) | -25.39% |
| Weighted Average Cost of Capital (WACC) | 16.53% |
| Revenue Per Employee | $348,606 |
| Profits Per Employee | -$985,977 |
| Employee Count | 132 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PTGX has paid $838,000 in taxes.
| Income Tax | 838,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +86.50% in the last 52 weeks. The beta is 2.24, so PTGX's price volatility has been higher than the market average.
| Beta (5Y) | 2.24 |
| 52-Week Price Change | +86.50% |
| 50-Day Moving Average | 86.78 |
| 200-Day Moving Average | 72.52 |
| Relative Strength Index (RSI) | 68.96 |
| Average Volume (20 Days) | 837,850 |
Short Selling Information
The latest short interest is 8.19 million, so 12.84% of the outstanding shares have been sold short.
| Short Interest | 8.19M |
| Short Previous Month | 8.44M |
| Short % of Shares Out | 12.84% |
| Short % of Float | 15.79% |
| Short Ratio (days to cover) | 12.67 |
Income Statement
In the last 12 months, PTGX had revenue of $46.02 million and -$130.15 million in losses. Loss per share was -$2.05.
| Revenue | 46.02M |
| Gross Profit | 46.02M |
| Operating Income | -158.13M |
| Pretax Income | -129.31M |
| Net Income | -130.15M |
| EBITDA | -156.85M |
| EBIT | -158.13M |
| Loss Per Share | -$2.05 |
Full Income StatementBalance Sheet
The company has $567.36 million in cash and $10.32 million in debt, with a net cash position of $635.68 million or $9.96 per share.
| Cash & Cash Equivalents | 567.36M |
| Total Debt | 10.32M |
| Net Cash | 635.68M |
| Net Cash Per Share | $9.96 |
| Equity (Book Value) | 614.71M |
| Book Value Per Share | 9.82 |
| Working Capital | 532.13M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $57.67 million and capital expenditures -$1.59 million, giving a free cash flow of $56.08 million.
| Operating Cash Flow | 57.67M |
| Capital Expenditures | -1.59M |
| Depreciation & Amortization | 1.28M |
| Net Borrowing | n/a |
| Free Cash Flow | 56.08M |
| FCF Per Share | $0.88 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -343.63% and -282.83%.
| Gross Margin | 100.00% |
| Operating Margin | -343.63% |
| Pretax Margin | -281.01% |
| Profit Margin | -282.83% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 121.87% |
Dividends & Yields
PTGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.31% |
| Shareholder Yield | 2.31% |
| Earnings Yield | -2.01% |
| FCF Yield | 0.86% |
Analyst Forecast
The average price target for PTGX is $106.67, which is 4.91% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $106.67 |
| Price Target Difference | 4.91% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 67.24% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PTGX has an Altman Z-Score of 39.15 and a Piotroski F-Score of 3.
| Altman Z-Score | 39.15 |
| Piotroski F-Score | 3 |
